Collectively these findings suggested that dysregulation of PDE4-cAMP signaling might be a potential convergent patho-molecular mechanism underpinning schizophrenia and other mental disorders and could provide a target for future drug development [230]. Here, PDE4A is linked to psychiatric disorder.